These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31648992)

  • 1. Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
    Feng X; Bao R; Li L; Deisenhammer F; Arnason BGW; Reder AT
    EBioMedicine; 2019 Nov; 49():269-283. PubMed ID: 31648992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.
    Reder AT; Velichko S; Yamaguchi KD; Hamamcioglu K; Ku K; Beekman J; Wagner TC; Perez HD; Salamon H; Croze E
    J Interferon Cytokine Res; 2008 May; 28(5):317-31. PubMed ID: 18547162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
    Hecker M; Hartmann C; Kandulski O; Paap BK; Koczan D; Thiesen HJ; Zettl UK
    Mol Neurobiol; 2013 Dec; 48(3):737-56. PubMed ID: 23636981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: deficient in vitro responses of blood mononuclear cells to IFN-beta.
    Huang YM; Hussien Y; Jin YP; Söderstrom M; Link H
    Acta Neurol Scand; 2001 Nov; 104(5):249-56. PubMed ID: 11696016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.
    Comabella M; Lünemann JD; Río J; Sánchez A; López C; Julià E; Fernández M; Nonell L; Camiña-Tato M; Deisenhammer F; Caballero E; Tortola MT; Prinz M; Montalban X; Martin R
    Brain; 2009 Dec; 132(Pt 12):3353-65. PubMed ID: 19741051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patients.
    Paap BK; Hundeshagen A; Hecker M; Zettl UK
    Curr Pharm Des; 2012; 18(29):4475-84. PubMed ID: 22612748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.
    Tanasescu R; Midgley A; Robins RA; Constantinescu CS
    Acta Neurol Scand; 2017 Sep; 136(3):233-238. PubMed ID: 27918083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a.
    Nguyen K; Olcer M; Howlett-Prieto Q; Feng X; Reder AT
    J Interferon Cytokine Res; 2023 Mar; 43(3):108-120. PubMed ID: 36867172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.
    Yamaguchi KD; Ruderman DL; Croze E; Wagner TC; Velichko S; Reder AT; Salamon H
    J Neuroimmunol; 2008 Mar; 195(1-2):116-20. PubMed ID: 18279974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β.
    De Felice B; Mondola P; Sasso A; Orefice G; Bresciamorra V; Vacca G; Biffali E; Borra M; Pannone R
    BMC Med Genomics; 2014 May; 7():26. PubMed ID: 24885345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: significant modulation of IL-17 and IL-23.
    Kürtüncü M; Tüzün E; Türkoğlu R; Petek-Balcı B; Içöz S; Pehlivan M; Birişik Ö; Ulusoy C; Shugaiv E; Akman-Demir G; Eraksoy M
    Cytokine; 2012 Aug; 59(2):400-2. PubMed ID: 22652415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis.
    Koike F; Satoh J; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T
    J Neuroimmunol; 2003 Jun; 139(1-2):109-18. PubMed ID: 12799028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression and translational approaches to identify biomarkers of interferon beta activity in multiple sclerosis.
    Croze E
    J Interferon Cytokine Res; 2010 Oct; 30(10):743-9. PubMed ID: 20874251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.
    Gilli F; Bertolotto A; Sala A; Hoffmann F; Capobianco M; Malucchi S; Glass T; Kappos L; Lindberg RL; Leppert D
    Brain; 2004 Feb; 127(Pt 2):259-68. PubMed ID: 14607790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.